• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Carcinoid syndome - Articles and news items

epr-logo

FDA extends PDUFA date for telotristat etiprate for the treatment of carcinoid syndrome

Industry news / 20 September 2016 / Niamh Louise Marriott, Digital Content Producer

In a notice from the FDA, the Prescription Drug User Fee Act date for its Priority Review of telotristat etiprate has been extended by three months…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +